PharmaCielo Ltd. (PCLO.V)
CAD 0.09
(-10.0%)
CAD 0.09
(-10.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 18.3 Million CAD | 45.45% |
| 2022 | 12.58 Million CAD | 49.31% |
| 2021 | 8.43 Million CAD | 88.46% |
| 2020 | 4.47 Million CAD | 184.47% |
| 2019 | 1.57 Million CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 19.24 Million CAD | 5.12% |
| 2024 Q2 | 20.14 Million CAD | 4.66% |
| 2023 Q3 | 16.79 Million CAD | 9.28% |
| 2023 Q4 | 18.3 Million CAD | 8.99% |
| 2023 FY | 18.3 Million CAD | 45.45% |
| 2023 Q1 | 14.28 Million CAD | 13.46% |
| 2023 Q2 | 15.37 Million CAD | 7.63% |
| 2022 FY | 12.58 Million CAD | 49.31% |
| 2022 Q2 | 9.97 Million CAD | 23.79% |
| 2022 Q1 | 8.05 Million CAD | -4.4% |
| 2022 Q4 | 12.58 Million CAD | 8.33% |
| 2022 Q3 | 11.61 Million CAD | 16.47% |
| 2021 Q1 | 4.23 Million CAD | -5.36% |
| 2021 FY | 8.43 Million CAD | 88.46% |
| 2021 Q4 | 8.43 Million CAD | 105.76% |
| 2021 Q3 | 4.09 Million CAD | 1.64% |
| 2021 Q2 | 4.03 Million CAD | -4.77% |
| 2020 Q2 | 1.45 Million CAD | -2.58% |
| 2020 Q4 | 4.47 Million CAD | 216.79% |
| 2020 FY | 4.47 Million CAD | 184.47% |
| 2020 Q1 | 1.49 Million CAD | -4.76% |
| 2020 Q3 | 1.41 Million CAD | -3.23% |
| 2019 Q3 | 1.38 Million CAD | -2.94% |
| 2019 Q2 | 1.42 Million CAD | -1.4% |
| 2019 Q1 | 1.44 Million CAD | 0.0% |
| 2019 FY | 1.57 Million CAD | 0.0% |
| 2019 Q4 | 1.57 Million CAD | 13.89% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.06 Million CAD | -261.562% |
| CanadaBis Capital Inc. | 7.3 Million CAD | -150.484% |
| Decibel Cannabis Company Inc. | 40.96 Million CAD | 55.305% |
| Delivra Health Brands Inc. | 2.02 Million CAD | -803.24% |
| Entourage Health Corp. | 161.58 Million CAD | 88.669% |
| Lifeist Wellness Inc. | 1.26 Million CAD | -1346.164% |
| Cannara Biotech Inc. | 45.78 Million CAD | 60.01% |
| Medicure Inc. | 544 Thousand CAD | -3265.565% |
| Rubicon Organics Inc. | 10.25 Million CAD | -78.455% |
| BioSyent Inc. | 1.22 Million CAD | -1399.426% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -45671.68% |